Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2005 3
2006 1
2007 9
2008 7
2009 5
2010 4
2011 6
2012 11
2013 4
2014 3
2015 5
2016 2
2017 5
2018 7
2019 7
2020 9
2021 9
2022 4
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Evinacumab for Homozygous Familial Hypercholesterolemia.
Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D; ELIPSE HoFH Investigators. Raal FJ, et al. N Engl J Med. 2020 Aug 20;383(8):711-720. doi: 10.1056/NEJMoa2004215. N Engl J Med. 2020. PMID: 32813947 Clinical Trial.
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.
Kanno K, Koseki M, Chang J, Saga A, Inui H, Okada T, Tanaka K, Asaji M, Zhu Y, Ide S, Saito S, Higo T, Okuzaki D, Ohama T, Nishida M, Kamada Y, Ono M, Saibara T, Yamashita S, Sakata Y. Kanno K, et al. Among authors: nishida m. Sci Rep. 2022 Feb 22;12(1):2996. doi: 10.1038/s41598-022-06542-8. Sci Rep. 2022. PMID: 35194060 Free PMC article.
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.
Morimoto K, Yamada T, Hirai S, Katayama Y, Fukui S, Sawada R, Tachibana Y, Matsui Y, Nakamura R, Ishida M, Kawachi H, Kunimasa K, Sasaki T, Nishida M, Furuya N, Watanabe S, Shiotsu S, Nishioka N, Horinaka M, Sakai T, Uehara H, Yano S, Son BK, Tokuda S, Takayama K. Morimoto K, et al. Among authors: nishida m. Cancer Lett. 2024 Apr 10;587:216692. doi: 10.1016/j.canlet.2024.216692. Epub 2024 Feb 9. Cancer Lett. 2024. PMID: 38342232 Free article.
XCR1+ conventional dendritic cell-induced CD4+ T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury.
Inui H, Nishida M, Ichii M, Nakaoka H, Asaji M, Ide S, Saito S, Saga A, Omatsu T, Tanaka K, Kanno K, Chang J, Zhu Y, Okada T, Okuzaki D, Matsui T, Ohama T, Koseki M, Morii E, Hosen N, Yamashita S, Sakata Y. Inui H, et al. Among authors: nishida m. J Mol Cell Cardiol. 2023 Mar;176:68-83. doi: 10.1016/j.yjmcc.2023.01.011. Epub 2023 Feb 3. J Mol Cell Cardiol. 2023. PMID: 36739942 Free article.
Accelerated Atherogenicity in Tangier Disease.
Muratsu J, Koseki M, Masuda D, Yasuga Y, Tomoyama S, Ataka K, Yagi Y, Nakagawa A, Hamada H, Fujita S, Hattori H, Ohama T, Nishida M, Hiraoka H, Matsuzawa Y, Yamashita S. Muratsu J, et al. Among authors: nishida m. J Atheroscler Thromb. 2018 Oct 1;25(10):1076-1085. doi: 10.5551/jat.43257. Epub 2018 Mar 20. J Atheroscler Thromb. 2018. PMID: 29563393 Free PMC article.
Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia.
Tanaka K, Koseki M, Kato H, Miyashita K, Okada T, Kanno K, Saga A, Chang J, Omatsu T, Inui H, Ohama T, Nishida M, Yamashita S, Sakata Y. Tanaka K, et al. Among authors: nishida m. J Atheroscler Thromb. 2023 Jan 1;30(1):100-104. doi: 10.5551/jat.63348. Epub 2022 Feb 18. J Atheroscler Thromb. 2023. PMID: 35185060 Free PMC article.
Pathophysiological significance of adiponectin.
Nishida M, Funahashi T, Shimomura I. Nishida M, et al. Med Mol Morphol. 2007 Jun;40(2):55-67. doi: 10.1007/s00795-007-0366-7. Epub 2007 Jun 18. Med Mol Morphol. 2007. PMID: 17572841 Review.
98 results